Creative Planning
IDYA icon

Creative Planning’s IDEAYA Biosciences IDYA Stock Holding History

Creative Planning’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Buy
150,582
+5,554
+4% +$170K ﹤0.01% 1315
2026
Q1 		$4.83M Buy
145,028
+8,973
+7% +$301K ﹤0.01% 1225
2025
Q4 		$4.7M Buy
136,055
+3,155
+2% +$101K ﹤0.01% 1047
2025
Q3 		$3.62M Buy
132,900
+11,216
+9% +$271K ﹤0.01% 1076
2025
Q2 		$2.56M Buy
121,684
+60,667
+99% +$1.16M ﹤0.01% 1139
2025
Q1 		$999K Buy
61,017
+42,618
+232% +$908K ﹤0.01% 1716
2024
Q4 		$473K Buy
18,399
+9,722
+112% +$275K ﹤0.01% 2275
2024
Q3 		$275K Buy
+8,677
New +$329K ﹤0.01% 2584
2024
Q2 		– Sell
-7,029
Closed -$308K – 3119
2024
Q1 		$308K Buy
7,029
+1,261
+22% +$54.2K ﹤0.01% 2230
2023
Q4 		$205K Buy
+5,768
New +$172K ﹤0.01% 2405

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Creative Planning's IDYA Position: Q2 2026 in Review

Creative Planning increased its IDEAYA Biosciences (IDYA) stake by 3.8% in Q2 2026, buying an estimated $170K and bringing the position to 150,582 shares worth $5.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

Creative Planning first reported a position in IDYA in Q4 2023 and has held it in 10 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Creative Planning held 150,582 shares of IDEAYA Biosciences worth $5.61M as of Q2 2026.
  • Creative Planning bought 5,554 IDEAYA Biosciences shares in Q2 2026, an estimated $170K.
  • IDEAYA Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1315 holding.
  • Creative Planning first reported a position in IDEAYA Biosciences in Q4 2023 and has held it in 10 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.